Literature DB >> 28932758

Iterative Image Processing for Early Diagnostic of Beta-Amyloid Plaque Deposition in Pre-Clinical Alzheimer's Disease Studies.

Nikolai V Slavine1, Padmakar V Kulkarni2, Roderick W McColl3.   

Abstract

PURPOSE: To test and evaluate an efficient iterative image processing strategy to improve the quality of sub-optimal pre-clinical PET images. A novel iterative resolution subsets-based method to reduce noise and enhance resolution (RSEMD) has been demonstrated on examples of PET imaging studies of Alzheimer's disease (AD) plaques deposition in mice brains.
MATERIALS AND METHODS: The RSEMD method was applied to imaging studies of non-invasive detection of beta-amyloid plaque in transgenic mouse models of AD. Data acquisition utilized a Siemens Inveon® micro PET/CT device. Quantitative uptake of the tracer in control and AD mice brains was determined by counting the extent of plaque deposition by histological staining. The pre-clinical imaging software inviCRO® was used for fitting the recovery PET images to the mouse brain atlas and obtaining the time activity curves (TAC) from different brain areas.
RESULTS: In all of the AD studies the post-processed images proved to have higher resolution and lower noise as compared with images reconstructed by conventional OSEM method. In general, the values of SNR reached a plateau at around 10 iterations with an improvement factor of about 2 over sub-optimal PET brain images.
CONCLUSIONS: A rapidly converging, iterative deconvolution image processing algorithm with a resolution subsets-based approach RSEMD has been used for quantitative studies of changes in Alzheimer's pathology over time. The RSEMD method can be applied to sub-optimal clinical PET brain images to improve image quality to diagnostically acceptable levels and will be crucial in order to facilitate diagnosis of AD progression at the earliest stages.

Entities:  

Keywords:  Alzheimer’s disease; Beta-amyloid plaque; Rapid converging; Resolution subsets-based iterative method; SNR improvement; Sub-optimal PET brain image recovery; Transgenic mouse model

Year:  2017        PMID: 28932758      PMCID: PMC5602576          DOI: 10.4172/2329-9533.1000134

Source DB:  PubMed          Journal:  J Appl Bioinforma Comput Biol        ISSN: 2329-9533


  26 in total

1.  Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.

Authors:  R Boellaard; A van Lingen; A A Lammertsma
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

Review 2.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

Review 3.  Amyloid imaging in Alzheimer's disease.

Authors:  Agneta Nordberg
Journal:  Curr Opin Neurol       Date:  2007-08       Impact factor: 5.710

4.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

Authors:  Kooresh Shoghi-Jadid; Gary W Small; Eric D Agdeppa; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Stephen Read; Nagichettiar Satyamurthy; Andrej Petric; Sung-Cheng Huang; Jorge R Barrio
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

5.  Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.

Authors:  C C Meltzer; J K Zubieta; J Brandt; L E Tune; H S Mayberg; J J Frost
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

6.  Quantitative accuracy of MAP reconstruction for dynamic PET imaging in small animals.

Authors:  Ju-Chieh Kevin Cheng; Kooresh Shoghi; Richard Laforest
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

7.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

8.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

9.  The synthesis and characterization of [(124)I]IMPY, a thioflavin-S derivative, in transgenic mouse models of Alzheimer's disease.

Authors:  K W Chang; C C Chen; S Y Lee; L H Shen; H E Wang
Journal:  Appl Radiat Isot       Date:  2009-02-20       Impact factor: 1.513

10.  In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

Authors:  Nicolaas P L G Verhoeff; Alan A Wilson; Shinichiro Takeshita; Liat Trop; Doug Hussey; Kernjit Singh; Hank F Kung; Mei-Ping Kung; Sylvain Houle
Journal:  Am J Geriatr Psychiatry       Date:  2004 Nov-Dec       Impact factor: 4.105

View more
  1 in total

1.  Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.

Authors:  Hyunjo Kim; Hyunwook Han
Journal:  Bioinformation       Date:  2018-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.